Cargando…
Network Pharmacology-Based and Experimental Identification of the Effects of Quercetin on Alzheimer’s Disease
Alzheimer’s disease (AD) is one of the neurodegenerative brain disorders inducing nearly half of dementia cases, and the diagnosis and treatment of AD are the primary issues clinically. However, there is a lack of effective biomarkers and drugs for AD diagnosis and therapeutics so far. In this study...
Autores principales: | Qi, Pingfang, Li, Jing, Gao, Shichao, Yuan, Yirong, Sun, Yindi, Liu, Na, Li, Yuanyuan, Wang, Gang, Chen, Ling, Shi, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645061/ https://www.ncbi.nlm.nih.gov/pubmed/33192484 http://dx.doi.org/10.3389/fnagi.2020.589588 |
Ejemplares similares
-
Network pharmacology identify intersection genes of quercetin and Alzheimer’s disease as potential therapeutic targets
por: Wei, Caihui, et al.
Publicado: (2022) -
Efficacy and Mechanism of Quercetin in the Treatment of Experimental Colitis Using Network Pharmacology Analysis
por: Zhang, Qilian, et al.
Publicado: (2022) -
Network Pharmacology-Based Strategy to Investigate the Pharmacologic Mechanisms of Coptidis Rhizoma for the Treatment of Alzheimer's Disease
por: Ye, Xian-wen, et al.
Publicado: (2022) -
Mechanisms of Quercetin against atrial fibrillation explored by network pharmacology combined with molecular docking and experimental validation
por: Tan, Xin, et al.
Publicado: (2022) -
Identification of Alzheimer's EEG With a WVG Network-Based Fuzzy Learning Approach
por: Yu, Haitao, et al.
Publicado: (2020)